BIOMAT Database Logo BIOMAT Database Logo

BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia. 2013

Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
From the Pathology Service (Drs Linskey, Gimbel, Zukerberg, Duncan, Sadow, and Nazarian); and the Dermatopathology Unit (Drs Linskey, Gimbel, Duncan, and Nazarian), Massachusetts General Hospital, Harvard Medical School, Boston.

BACKGROUND Basaloid squamous cell carcinoma (bSCC) is an uncommon variant of squamous cell carcinoma, which may overlap histologically with basal cell carcinoma with squamous metaplasia (BCCm). OBJECTIVE To aid in the differentiation of these neoplasms using immunohistochemical staining because of the worse prognosis associated with bSCC. METHODS Using immunohistochemical techniques, we investigated BerEp4, cytokeratin 17 (CK17), and cytokeratin 14 (CK14) protein expression in 25 cases of bSCC (8 cutaneous [32%], 12 aerodigestive tract [48%], and 5 lymph node metastases [20%]) and 43 cases of BCCm (39 cutaneous [91%], and 4 metastases [9%]). An immunoreactivity score was assigned using the percentage of tumor cells staining and the pattern of expression. Interobserver agreement for 2 independent pathologists was assessed using a κ coefficient. RESULTS The mean percentage of staining was significantly higher in BCCm, compared with bSCC (BerEp4, P = .006; CK17, P < .001; CK14, P < .001; unpaired t test), with 58% of BCCm cases (25 of 43) displaying diffuse staining for all markers, and nearly all (98%; 42 of 43) displaying diffuse staining for CK17 and CK14. In contrast, no bSCC cases (0%) displayed diffuse staining for all 3 markers, and only 8% (2 of 25) displayed diffuse staining for CK17 and CK14. High interobserver agreement was determined. CONCLUSIONS BerEp4 alone is unreliable for differentiation between BCCm and bSCC, and the addition of either CK14 or CK17 will augment the sensitivity and negative predictive value of BerEp4 staining in BCCm and bSCC diagnosis.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008679 Metaplasia A condition in which there is a change of one adult cell type to another similar adult cell type.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D002281 Carcinoma, Basosquamous A skin carcinoma that histologically exhibits both basal and squamous elements. (From Dorland, 27th ed) Basosquamous Carcinoma,Basosquamous Carcinomas,Carcinomas, Basosquamous
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004067 Digestive System Neoplasms Tumors or cancer of the DIGESTIVE SYSTEM. Cancer of Digestive System,Digestive System Cancer,Cancer of the Digestive System,Neoplasms, Digestive System,Cancer, Digestive System,Cancers, Digestive System,Digestive System Cancers,Digestive System Neoplasm,Neoplasm, Digestive System

Related Publications

Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
October 2009, Journal of cutaneous pathology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
CD34 and BerEP4 Are Helpful to Distinguish Basaloid Tricholemmoma From Basal Cell Carcinoma.
August 2018, The American Journal of dermatopathology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal.
April 2015, Annals of diagnostic pathology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
August 2005, Journal of cutaneous pathology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma.
August 2012, Journal of cancer research and clinical oncology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.
November 2021, The American Journal of dermatopathology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature.
March 2008, Gynecologic oncology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Basaloid squamous cell carcinoma versus basal cell ameloblastoma.
March 1998, Oral oncology,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
The Use of BEREP4 Immunohistochemistry Staining for Detection of Basal Cell Carcinoma.
January 2017, Journal of skin cancer,
Katy R Linskey, and Devon C Gimbel, and Lawrence R Zukerberg, and Lyn M Duncan, and Peter M Sadow, and Rosalynn M Nazarian
Cytokeratin 20 expression in basaloid follicular hamartoma and infundibulocystic basal cell carcinoma.
December 2014, Journal of cutaneous pathology,
Copied contents to your clipboard!